LivaNova (LIVN) Net Margin Growth (1y) (2015 - 2026)
LivaNova (LIVN) Net Margin Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -314.00 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 123.00 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 94.00 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1,132.00 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 656.00 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 201.00 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -430.00 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | LivaNova | 4.30 Bn | 3.76 Bn | 243.75 Mn | 10,969.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10,969.00 |
| Dec 31, 2025 | -880.00 |
| Sep 30, 2025 | -286.00 |
| Jun 30, 2025 | 257.00 |
| Mar 31, 2025 | -8,908.00 |
| Dec 31, 2024 | 1,209.00 |
| Sep 30, 2024 | 1,289.00 |
| Jun 30, 2024 | 473.00 |
| Mar 31, 2024 | -1,702.00 |
| Dec 31, 2023 | 466.00 |
| Sep 30, 2023 | 3,997.00 |
| Jun 30, 2023 | -608.00 |
| Mar 31, 2023 | 155.00 |
| Dec 31, 2020 | -25.00 |
| Dec 31, 2019 | 41.00 |
| Jun 30, 2019 | 162.00 |
| Dec 31, 2018 | 2,848.00 |
| Sep 30, 2018 | -66.00 |
| Jun 30, 2018 | -226.00 |
| Mar 31, 2018 | -95.00 |